Loading page…
Healthcare
Solventum Corporation is assigned an AlphaScore of 69/100 in the Healthcare sector, underpinned by a solid return on equity (roe) of 30.82% and a gross margin of 53.47%. A notable strength for the company is its strong momentum subscore of 74, showing favorable trading behavior. Conversely, a primary risk is its debt-to-equity ratio of 1.00, which points to higher leverage compared to some peers alongside a relatively modest revenue growth of 0.86%. The snapshot lists the stock price at $87.29 with a trailing price-to-earnings (pe) ratio of 10.68 and a forward PE of 12.07. Net margin sits at 18.69%, and market capitalization totals $14.86 billion with no dividend currently paid. Evidence is limited to the provided 2026-10-11 record.
Written 11/10/2026, 00:38:56 UTC · Snapshot 11/10/2026